Trade Longeveron Inc. - LGVN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.53 |
| Open | 1.54 |
| 1-Year Change | -51.57% |
| Day's Range | 1.47 - 1.54 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1.53 | 0.02 | 1.32% | 1.51 | 1.56 | 1.41 |
| Mar 28, 2025 | 1.57 | -0.09 | -5.42% | 1.66 | 1.67 | 1.50 |
| Mar 27, 2025 | 1.71 | 0.01 | 0.59% | 1.70 | 1.72 | 1.64 |
| Mar 26, 2025 | 1.68 | -0.07 | -4.00% | 1.75 | 1.75 | 1.67 |
| Mar 25, 2025 | 1.77 | -0.07 | -3.80% | 1.84 | 1.86 | 1.73 |
| Mar 24, 2025 | 1.82 | -0.04 | -2.15% | 1.86 | 1.88 | 1.77 |
| Mar 21, 2025 | 1.80 | 0.06 | 3.45% | 1.74 | 1.81 | 1.71 |
| Mar 20, 2025 | 1.73 | 0.07 | 4.22% | 1.66 | 1.85 | 1.66 |
| Mar 19, 2025 | 1.70 | 0.08 | 4.94% | 1.62 | 1.73 | 1.62 |
| Mar 18, 2025 | 1.64 | -0.01 | -0.61% | 1.65 | 1.69 | 1.61 |
| Mar 17, 2025 | 1.69 | 0.04 | 2.42% | 1.65 | 1.73 | 1.65 |
| Mar 14, 2025 | 1.64 | 0.02 | 1.23% | 1.62 | 1.67 | 1.60 |
| Mar 13, 2025 | 1.62 | -0.03 | -1.82% | 1.65 | 1.70 | 1.58 |
| Mar 12, 2025 | 1.66 | 0.11 | 7.10% | 1.55 | 1.73 | 1.51 |
| Mar 11, 2025 | 1.50 | 0.01 | 0.67% | 1.49 | 1.56 | 1.39 |
| Mar 10, 2025 | 1.47 | 0.03 | 2.08% | 1.44 | 1.48 | 1.39 |
| Mar 7, 2025 | 1.48 | 0.02 | 1.37% | 1.46 | 1.53 | 1.39 |
| Mar 6, 2025 | 1.42 | 0.09 | 6.77% | 1.33 | 1.48 | 1.33 |
| Mar 5, 2025 | 1.36 | 0.05 | 3.82% | 1.31 | 1.39 | 1.30 |
| Mar 4, 2025 | 1.34 | 0.07 | 5.51% | 1.27 | 1.35 | 1.21 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Longeveron Inc Company profile
Longeveron Inc. (LGVN) is a clinical-stage biotechnology company. Its lead drug component and cellular therapies address ageing and other life-threatening conditions. Founded in 2014, Longeveron is headquartered in Miami, US.
The biotech firm’s leading product Lomecel-B is derived from culture-expanded medicinal signalling cells (MSCs). The cells were sourced from young healthy adult donors’ - aged 18 to 45 - bone marrow to treat ageing-related diseases as they promote cell and tissue repair, organ maintenance and immune system function.
As of June 2022, the company is conducting Phase 2 clinical trials in hypoplastic left heart syndrome (HLHS) and Alzheimer’s disease. It has received orphan drug and rare paediatric disease designations from the US Food and Drug Administration (FDA).
Longeveron is also conducting Phase 1 and 2 clinical trials for ageing frailty, metabolic syndrome and acute respiratory distress syndrome due to Covid-19 or influenza.
Longeveron’s programmes have been awarded grant funding of more than $16.2m from various organisations, including the National Institute on Ageing (NIA), National Heart Lung and Blood Institute (NHLBI), the Alzheimer’s Association and the Maryland Stem Cell Research Fund (MSCRF).
Longeveron Inc. stock started trading on the NASDAQ stock exchange in February 2021 under the ticker symbol LGVN.
You can follow live LGVN stock price movements and price history and keep up with the latest LGVN share value at Capital.com
| Industry: | Biotechnology & Medical Research (NEC) |
1951 NW 7th Ave
Ste 520
MIAMI
FLORIDA 33136
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com